Sort by

Send to

Choose Destination

Search results

Items: 5


Synthesis and in silico evaluation of novel compounds for PET-based investigations of the norepinephrine transporter.

Neudorfer C, Seddik A, Shanab K, Jurik A, Rami-Mark C, Holzer W, Ecker G, Mitterhauser M, Wadsak W, Spreitzer H.

Molecules. 2015 Jan 20;20(1):1712-30. doi: 10.3390/molecules20011712.


Development of potential selective and reversible pyrazoline based MAO-B inhibitors as MAO-B PET tracer precursors and reference substances for the early detection of Alzheimer's disease.

Neudorfer C, Shanab K, Jurik A, Schreiber V, Neudorfer C, Vraka C, Schirmer E, Holzer W, Ecker G, Mitterhauser M, Wadsak W, Spreitzer H.

Bioorg Med Chem Lett. 2014 Sep 15;24(18):4490-4495. doi: 10.1016/j.bmcl.2014.07.085. Epub 2014 Aug 7.


Impact of co-administered drugs on drug monitoring of capecitabine in patients with advanced colorectal cancer.

Schreiber V, Kitzmueller M, Poxhofer M, Gintersdorfer S, Neudorfer C, Lichtneckert M, Dittrich C, Czejka M.

Anticancer Res. 2014 Jul;34(7):3371-6.


A one-step microwave-assisted synthetic method for an O/S-chemoselective route to derivatives of the first adenosine A3 PET radiotracer.

Shanab K, Neudorfer C, Holzer W, Mitterhauser M, Wadsak W, Spreitzer H.

Molecules. 2014 Apr 2;19(4):4076-82. doi: 10.3390/molecules19044076.


Syntheses of precursors and reference compounds of the melanin-concentrating hormone receptor 1 (MCHR1) tracers [¹¹C]SNAP-7941 and [¹⁸F]FE@SNAP for positron emission tomography.

Schirmer E, Shanab K, Datterl B, Neudorfer C, Mitterhauser M, Wadsak W, Philippe C, Spreitzer H.

Molecules. 2013 Sep 30;18(10):12119-43. doi: 10.3390/molecules181012119.

Supplemental Content

Loading ...
Support Center